en
Scientific article
English

DDR1 role in fibrosis and its pharmacological targeting

Published inBiochimica et Biophysica Acta - Molecular Cell Research, vol. 1866, no. 11, 118474
Publication date2019
Abstract

Discoidin domain receptor1 (DDR1) is a collagen activated receptor tyrosine kinase and an attractive anti-fibrotic target. Its expression is mainly limited to epithelial cells located in several organs including skin, kidney, liver and lung. DDR1's biology is elusive, with unknown downstream activation pathways; however, it may act as a mediator of the stromal-epithelial interaction, potentially controlling the activation state of the resident quiescent fibroblasts. Increased expression of DDR1 has been documented in several types of cancer and fibrotic conditions including skin hypertrophic scars, idiopathic pulmonary fibrosis, cirrhotic liver and renal fibrosis. The present review article focuses on: a) detailing the evidence for a role of DDR1 as an anti-fibrotic target in different organs, b) clarifying DDR1 tissue distribution in healthy and diseased tissues as well as c) exploring DDR1 protective mode of action based on literature evidence and co-authors experience; d) detailing pharmacological efforts attempted to drug this subtle anti-fibrotic target to date.

Citation (ISO format)
MOLL, Solange et al. DDR1 role in fibrosis and its pharmacological targeting. In: Biochimica et Biophysica Acta - Molecular Cell Research, 2019, vol. 1866, n° 11, p. 118474. doi: 10.1016/j.bbamcr.2019.04.004
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0167-4889
324views
3downloads

Technical informations

Creation09/03/2019 12:41:00 PM
First validation09/03/2019 12:41:00 PM
Update time03/15/2023 5:59:22 PM
Status update03/15/2023 5:59:22 PM
Last indexation01/17/2024 6:12:02 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack